Your browser doesn't support javascript.
loading
Modulation of Radiation Biomarkers in a Randomized Phase II Study of 131I-MIBG With or Without Radiation Sensitizers for Relapsed or Refractory Neuroblastoma.
Campbell, Kevin; Groshen, Susan; Evans, Angela C; Wilson, Stephen; Sebastian, Aimy; Loots, Gabriela G; Marachelian, Araz; Armant, Myriam; Pal, Sharmistha; Haas-Kogan, Daphne A; Park, Julie R; Granger, Meaghan; Matthay, Katherine K; Coleman, Matthew A; DuBois, Steven G.
Afiliação
  • Campbell K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts.
  • Groshen S; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Evans AC; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California; Department of Radiation Oncology, University of California, Davis School of Medicine, Sacramento, California.
  • Wilson S; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California.
  • Sebastian A; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California.
  • Loots GG; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California.
  • Marachelian A; Children's Hospital of Los Angeles, Los Angeles, California.
  • Armant M; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts.
  • Pal S; Department of Radiation Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Haas-Kogan DA; Department of Radiation Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Park JR; Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington.
  • Granger M; Hematology and Oncology Center, Cook Children's Medical Center, Fort Worth, Texas.
  • Matthay KK; Department of Pediatrics and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
  • Coleman MA; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California; Department of Radiation Oncology, University of California, Davis School of Medicine, Sacramento, California.
  • DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts. Electronic address: steven_dubois@dfci.harvard.edu.
Int J Radiat Oncol Biol Phys ; 115(5): 1115-1128, 2023 04 01.
Article em En | MEDLINE | ID: mdl-36526235
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radiossensibilizantes / Neuroblastoma Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Int J Radiat Oncol Biol Phys Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radiossensibilizantes / Neuroblastoma Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Int J Radiat Oncol Biol Phys Ano de publicação: 2023 Tipo de documento: Article